Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation "START"

Recruiting

Phase 3 Results N/A

Summary of Purpose

Title: Optimal Delay Time to Initiate Anticoagulation after Ischemic Stroke in Atrial Fibrillation (START): a pragmatic, adaptive randomized clinical trial. Primary Objective: • To determine the optimal time to initiate anticoagulation with a Non-Vitamin K Oral Anticoagulant (NOAC) after ischemic stroke in patients with non-valvular atrial fibrillation. Secondary Objectives: - To...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 June 2017.

14 Jun 2017 12 Jan 2017 1 Jun 2021 1 Aug 2021 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts